Follow the 바이오스마트 stock price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares are quoted on the KR market, under the supervision of DART (FSS). Operating in the Technology sector, 바이오스마트 has recorded 33 public disclosures. Market capitalisation: €73.8bn. The latest transaction was reported on 15 July 2026 (Purchase). Among the most active insiders: 박혜린. All data is accessible without an account.
30
Insider Decl.
n/a
Thresholds
n/a
22 ops.
Buy Volume
n/a
1 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 16,878 of 29,062 companies
47.3
score / 100
Value
64
Quality
31
FCF yld-14%
Earn yld13%
EV/EBITDA5.8x
ROE·
Gross mgn18%
Net mgn1.9%
Debt/EBITDA3.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.